From http://projects.propublica.org/docdollars. © Copyright 2013 Pro Publica Inc.
In recent years, drug companies have started releasing details of the payments they make to doctors and other health professionals for promotional talks, research and consulting. As of 2012, 15 companies published the information, most because of legal settlements. Use this tool to search for payments. Read more about the data »
Interested in downloading the data? Go to the ProPublica Data Store.
With 2.1 Million records, this database represents:
$2.5 billion
in disclosed payments
15
companies
~ 43%
of total market share
Payments in Your State
Click on a state to see payments made to practitioners and institutions there. See notes below.
| State | Total |
| Alabama | $32,352,175 |
| Alaska | $516,535 |
| Arizona | $38,739,643 |
| Arkansas | $15,599,178 |
| California | $298,077,233 |
| Colorado | $37,667,949 |
| Connecticut | $33,936,255 |
| Delaware | $4,263,545 |
| District of Columbia | $10,078,629 |
| Florida | $214,234,452 |
| Georgia | $72,421,234 |
| Hawaii | $3,879,724 |
| Idaho | $9,540,294 |
| Illinois | $82,167,799 |
| Indiana | $49,917,839 |
| Iowa | $12,473,968 |
| Kansas | $31,316,568 |
| Kentucky | $32,053,020 |
| Louisiana | $28,144,888 |
| Maine | $4,364,410 |
| Maryland | $65,145,277 |
| Massachusetts | $116,770,909 |
| Michigan | $58,090,460 |
| Minnesota | $34,654,974 |
| Mississippi | $11,142,272 |
| Missouri | $61,853,638 |
| Montana | $3,469,361 |
| Nebraska | $28,517,569 |
| Nevada | $16,562,819 |
| New Hampshire | $7,250,849 |
| New Jersey | $68,228,948 |
| New Mexico | $8,222,340 |
| New York | $172,120,803 |
| North Carolina | $96,518,819 |
| North Dakota | $5,485,004 |
| Ohio | $101,752,456 |
| Oklahoma | $23,750,987 |
| Oregon | $26,273,462 |
| Pennsylvania | $115,312,622 |
| Rhode Island | $14,542,297 |
| South Carolina | $50,615,778 |
| South Dakota | $3,678,498 |
| Tennessee | $56,781,581 |
| Texas | $205,287,519 |
| Utah | $31,494,606 |
| Vermont | $2,549,397 |
| Virginia | $40,174,768 |
| Washington | $43,967,071 |
| West Virginia | $7,378,715 |
| Wisconsin | $26,768,200 |
| Wyoming | $519,174 |
| Puerto Rico | $15,206,630 |
| [Unknown State] | $875,458 |
Company Disclosures
The totals listed here cover different time periods and spending categories, and aren't directly comparable. See notes below. See what each company discloses »
| Company | Total Disclosed |
|---|---|
|
AbbVie Disclosed: July to Dec., 2012 |
$18M |
|
Allergan Disclosed: July 2011 to Dec. 2012 |
Ranges* |
|
AstraZeneca Disclosed: Jan. 2010 to Dec. 2012 |
$275.3M |
|
Cephalon Disclosed: Jan. 2009 to Dec. 2012 |
$89.6M |
|
Eli Lilly Disclosed: Jan. 2009 to Dec. 2012 |
$608.8M |
|
EMD Serono Disclosed: Jan. 2011 to Dec. 2012 |
$4.4M |
|
Forest Disclosed: Jan. to Dec. 2012 |
$99.3M |
|
GlaxoSmithKline Disclosed: April 2009 to Dec. 2012 |
$326.3M |
|
Johnson & Johnson Disclosed: Jan. 2010 to Dec. 2012 |
$68.4M |
|
Merck Disclosed: July 2009 to Dec. 2012 |
$282.7M |
|
Novartis Disclosed: Oct. 2010 to Dec. 2012 |
$115.8M |
|
Pfizer Disclosed: July 2009 to Dec. 2012 |
$583.5M |
|
UCB Disclosed: Jan. to Dec., 2012 |
$30.1M |
|
Valeant Disclosed: Jan. 10, 2010 to Dec. 2012 |
Ranges* |
|
ViiV Disclosed: Jan. 2010 to Dec. 2012 |
$29.3M |
Notes: Companies report different types of payments for different time periods. Payments made after December 2012 are not reflected on this website. Because they are reported in ranges, some of Valeant's payments and all of Allergan's payments are excluded from state and national totals. No payments are listed for Novartis from Oct. 1, 2011 to Dec. 31, 2011 or for Valeant between Sept. 27, 2010 and Jan. 1, 2011.
Local Stories Based on This Data
See recent stories that use our data below. Interested in being notified when we update our app? Find out how.
- St. Louis Post-Dispatch: St. Louis physicians speak for drugmakers' dollars
- St. Louis Business Journal: These St. Louis doctors received big paydays to speak for drug makers
- SaukValley.com: Local doctor is in … the money
- Houston Chronicle: Doctors scrutinized for potential conflicts of interest.
- KRGV: Dollars for Doctors
Our Stories
As Full Disclosure Nears, Doctors’ Pay for Drug Talks Plummets
As transparency increases and blockbuster drugs lose patent protection, drug companies have dramatically scaled back payments to doctors for promotional talks. This fall, all drug and medical device companies will be required to report payments to doctors.
Freed of Disclosure Requirement, Drug Maker Pulls Doctor Payments Offline
Drugmaker Cephalon had been required to post its payments to doctors online as part of a lawsuit settlement. After its agreement expired, it removed them from its website.
Dollars for Docs Mints a Millionaire
New data show drugmakers' payments to hundreds of thousands of doctors, and some have made well over $500,000.
Background Stories
Big Pharma’s Big FinesReporters, Use Our Data
Have questions about how you can best use Dollars for Docs for your own localized reporting? Contact Nicole Collins Bronzan at communications@propublica.org.
Additional reporting and development by Jason Das, Liz Day, David Frackman, Jennifer LaFleur, Jeff Larson, Dan Nguyen, Mike Tigas and Sisi Wei. Pharmacy icon from The Noun Project. The 2012 market share for the companies included in this tool was calculated using data from IMS Health, a health care information company.